Use of Statins, Anticoagulants, Antiaggregants and Antiarrhythmic Drugs in Patients With COVID-19. The Agreed Experts' Position of Russian Society of Cardiology, Eurasian Association of Therapists, National Society on Atherothrombosis, Societies of Experts in Urgent Cardiology, Eurasian Arrhythmology Association
This article discusses relevant aspects in the treatment of patients with COVID-19. Up-to-date information about principles for administration of statins, antithrombotics, and antiarrhythmics is presented. The authors addressed in detail specific features of reversing heart rhythm disorders in patients with coronavirus infection and the interaction of antiarrhythmic and antiviral drugs. Recommendations are provided for outpatient and inpatient antithrombotic therapy for patients with COVID-19. Issues of antithrombotic and antiviral drug interaction are discussed.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
|---|---|
| Enthalten in: |
Kardiologiia - 60(2020), 6 vom: 25. Mai, Seite 1180 |
| Sprache: |
Russisch |
|---|
| Beteiligte Personen: |
Shlyakhto, Ye V [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anti-Arrhythmia Agents |
|---|
| Anmerkungen: |
Date Completed 29.07.2020 Date Revised 07.12.2022 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.18087/cardio.2020.6.n1180 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM312964064 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM312964064 | ||
| 003 | DE-627 | ||
| 005 | 20231225145541.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.18087/cardio.2020.6.n1180 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1043.xml |
| 035 | |a (DE-627)NLM312964064 | ||
| 035 | |a (NLM)32720611 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 100 | 1 | |a Shlyakhto, Ye V |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Use of Statins, Anticoagulants, Antiaggregants and Antiarrhythmic Drugs in Patients With COVID-19. The Agreed Experts' Position of Russian Society of Cardiology, Eurasian Association of Therapists, National Society on Atherothrombosis, Societies of Experts in Urgent Cardiology, Eurasian Arrhythmology Association |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.07.2020 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a This article discusses relevant aspects in the treatment of patients with COVID-19. Up-to-date information about principles for administration of statins, antithrombotics, and antiarrhythmics is presented. The authors addressed in detail specific features of reversing heart rhythm disorders in patients with coronavirus infection and the interaction of antiarrhythmic and antiviral drugs. Recommendations are provided for outpatient and inpatient antithrombotic therapy for patients with COVID-19. Issues of antithrombotic and antiviral drug interaction are discussed | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Practice Guideline | |
| 650 | 7 | |a Anti-Arrhythmia Agents |2 NLM | |
| 650 | 7 | |a Anticoagulants |2 NLM | |
| 650 | 7 | |a Hydroxymethylglutaryl-CoA Reductase Inhibitors |2 NLM | |
| 700 | 1 | |a Arutyunov, G P |e verfasserin |4 aut | |
| 700 | 1 | |a Belenkov, Yu N |e verfasserin |4 aut | |
| 700 | 1 | |a Tarlovskaya, E I |e verfasserin |4 aut | |
| 700 | 1 | |a Konradi, A O |e verfasserin |4 aut | |
| 700 | 1 | |a Panchenko, E P |e verfasserin |4 aut | |
| 700 | 1 | |a Yavelov, I S |e verfasserin |4 aut | |
| 700 | 1 | |a Tereshchenko, S N |e verfasserin |4 aut | |
| 700 | 1 | |a Ardashev, A V |e verfasserin |4 aut | |
| 700 | 1 | |a Arutyunov, A G |e verfasserin |4 aut | |
| 700 | 1 | |a Grigorieva, N Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Dzhunusbekova, G A |e verfasserin |4 aut | |
| 700 | 1 | |a Drapkina, O M |e verfasserin |4 aut | |
| 700 | 1 | |a Koziolova, N A |e verfasserin |4 aut | |
| 700 | 1 | |a Komarov, A L |e verfasserin |4 aut | |
| 700 | 1 | |a Kropacheva, E S |e verfasserin |4 aut | |
| 700 | 1 | |a Malchikova, S V |e verfasserin |4 aut | |
| 700 | 1 | |a Mitkovskaya, N P |e verfasserin |4 aut | |
| 700 | 1 | |a Orlova, Ya A |e verfasserin |4 aut | |
| 700 | 1 | |a Petrova, M M |e verfasserin |4 aut | |
| 700 | 1 | |a Rebrov, A P |e verfasserin |4 aut | |
| 700 | 1 | |a Sisakian, H |e verfasserin |4 aut | |
| 700 | 1 | |a Skibitsky, V V |e verfasserin |4 aut | |
| 700 | 1 | |a Sugraliyev, A B |e verfasserin |4 aut | |
| 700 | 1 | |a Fomin, I V |e verfasserin |4 aut | |
| 700 | 1 | |a Chesnikova, A I |e verfasserin |4 aut | |
| 700 | 1 | |a Shaposhnik, I I |e verfasserin |4 aut | |
| 700 | 1 | |a Zhelyakov, E G |e verfasserin |4 aut | |
| 700 | 1 | |a Kanorskii, S G |e verfasserin |4 aut | |
| 700 | 1 | |a Kolotsey, L V |e verfasserin |4 aut | |
| 700 | 1 | |a Snezhitskiy, V A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Kardiologiia |d 1961 |g 60(2020), 6 vom: 25. Mai, Seite 1180 |w (DE-627)NLM000007153 |x 0022-9040 |7 nnns |
| 773 | 1 | 8 | |g volume:60 |g year:2020 |g number:6 |g day:25 |g month:05 |g pages:1180 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18087/cardio.2020.6.n1180 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 60 |j 2020 |e 6 |b 25 |c 05 |h 1180 | ||